In a notification issued on July 13^th 2021, the National Pharmaceutical Pricing Authority (NPPA), has capped the trade margin via a notification for Pulse Oximeter, Blood Pressure Monitoring Machine, Nebulizer, Digital Thermometer and Glucometer.

The revised MRP is effective July 20^th 2021 as per the statement issued by NPPA.

The margin was capped up to 70% on the Price to Distributor (PTD) level. Pursuant thereto, a total of 684 products/brands of these medical devices have been reported as of 23rd July 2021 and 620 products/brands (91%) have reported downward revision of MRP.

The maximum downward revision has been reported by the imported brand of Pulse Oximeter, showing a reduction of Rs. 2,95,375 per unit.

The downward revision of MRP has been reported by imported and domestic brands across all the categories. The highest reduction in prices for Pulse Oximeters, Blood Pressure Monitoring Machine and Nebulizer has been reported by importers.

The revised MRP effective from 20th July 2021 on all the brands and specifications has been shared with the State Drug Controllers for strict monitoring and enforcement. The relevant instructions are available on NPPA’s website (www.nppa.gov.in). To monitor availability, the manufacturers/importers of these medical devices have been directed to submit quarterly stock details.

This move by the NPPA has received all-around support from industry associations like FICCI, AdvaMed and AMCHAM.